Mastology 2021
DOI: 10.29289/259453942021v31s2063
|View full text |Cite
|
Sign up to set email alerts
|

Management of the Axilla in Patients With Breast Cancer and One Out of One Positive Sentinel Lymph Node. Can We Omit Axillary Lymph Node Clearance?

Abstract: Background: Over the past three decades, the treatment of the axilla in breast cancer management continues to change. Current treatment strategies aim to achieve regional nodal control associated with reduced incidence of lymphedema and other long-term complications. In this study, we analyzed our tertiary center’s database of patients who had a single retrieved sentinel node (SN) that was positive for macrometastatic disease. We focused on AMAROS trial outcomes and the future view of treating this cohort of p… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles